Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus

European Journal of Endocrinology

Volumn 165, Issue 4, 2011, Pages 597-601

  Wu, Dandong ^a   Li, Ng ^a   Yang, Mengliu ^a   Liu, Hua ^b   Yang, Gangyi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEONECTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETOGENESIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE REGULATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGING; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY; OSTEONECTIN; REGRESSION ANALYSIS; SEX CHARACTERISTICS;

EID: 80053553416     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0131     Document Type: Article

References (18)

1. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML & Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981 26 99-105. (doi:10.1016/0092-8674(81)90037-4)
2. Kos K, Wong S, Tan B, Gummesson A, Jernas M, Franck N, Kerrigan D, Nystrom FH, Carlsson LM, Randeva HS, Pinkney JH &Wilding JP. Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes 2009 58 1780-1788. (doi:10.2337/db09-0211)
3. Sage H, Johnson C & Bornstein P. Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. Journal of Biological Chemistry 1984 259 3993-4007. (Pubitemid 14170117)
4. Reed MJ & Sage EH. SPARC and the extracellular matrix: implications for cancer and wound repair. Current Topics in Microbiology and Immunology 1996 213 81-94. (Pubitemid 26165087)
5. Bradshaw AD, Reed MJ & Sage EH. SPARC-null mice exhibit accelerated cutaneous wound closure. Journal of Histochemistry and Cytochemistry 2002 50 1-10. (doi:10.1177/002215540205000101)
6. Camino AM, Atorrasagasti C & Maccio D. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. Journal of Gene Medicine 2008 10 993-1004. (doi:10.1002/jgm.1228)
7. Bradshaw AD, Graves DC, Motamed K & Sage EH. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. PNAS 2003 100 6045-6050. (doi:10.1073/pnas.1030790100)
8. Tartare-Deckert S, Chavey C, Monthouel MN, Gautier N & van Obberghen E. The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. Journal of Biological Chemistry 2001 276 22231-22237. (doi:10.1074/jbc.M010634200)
9. Gilbert RE, McNally PG, Cox A, Dziadek M, Rumble J, Cooper ME &Jerums G. SPARC gene expression is reduced in early diabetes-related kidney growth. Kidney International 1995 48 1216-1225. (doi:10.1038/ki.1995.405)
10. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG & Alpers CE. Amelioration of diabetic nephropathy in SPARC-null mice. Journal of the American Society of Nephrology 2003 14 968-980. (doi:10.1097/01.ASN. 0000054498.83125.90)
11. Watanabe K, Okamoto F, Yokoo T, Iida KT, Suzuki H, Shimano H, Oshika T, Yamada N & Toyoshima H. SPARC is a major secretory gene expressed and involved in the development of proliferative diabetic retinopathy. Journal of Atherosclerosis and Thrombosis 2009 16 69-76. (doi:10.5551/jat.E711)
12. Munjal ID, McLean NV, Grant MB & Blake DA. Differences in the synthesis of secreted proteins in human retinal endothelial cells of diabetic and nondiabetic origin. Current Eye Research 1994 13 303-310. (doi:10.3109/02713689408995792)
13. Deurenberg P, Weststrate JA & Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. British Journal of Nutrition 1991 65 105-114. (doi:10.1079/BJN19910073)
14. Mansergh FC, Wells T, Elford C, Evans SL, Perry MJ, Evans MJ &Evans BA. Osteopenia in SPARC (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiological Genomics 2007 32 64-73. (doi:10.1152/physiolgenomics.00151.2007)
15. Nie J & Sage EH. SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. Journal of Biological Chemistry 2009 284 1279-1290. (doi:10.1074/jbc.M808285200)
16. Kos K & Wilding JP. SPARC: a key player in the pathologies associated with obesity and diabetes. Nature Reviews. Endocrinology 2010 6 225-235. (doi:10.1038/nrendo.2010.18)
17. Alvarez MJ, Prada F, Salvatierra E, Bravo AI, Lutzky VP, Carbone C, Pitossi FJ, Chuluyan HE & Podhajcer OL. Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Research 2005 65 5123-5132. (doi:10.1158/0008-5472.CAN-04-1102)
18. Shiba H, Fujita T, Doi N, Nakamura S, Nakanishi K, Takemoto T, Hino T, Noshiro M, Kawamoto T, Kurihara H & Kato Y. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. Journal of Cellular Physiology 1998 174 194-205. (doi:10.1002/(SICI)1097-4652(199802)174:2〈194: :AID-JCP7〉3.0.CO;2-J)